ImmunoGen, Inc.
Anti-FOLR1 Immunoconjugate Dosing Regimens

Abstract:

Methods of administering immunoconjugates that bind to FOLR1 are provided. The methods comprise administering an anti-FOLR1 immunoconjugate to a person in need thereof, for example, a cancer patient, at a therapeutically effective dosing regimen that results in minimal adverse effects.